Language Select
Varian Logo

Press Releases

October 25, 2017
Fourth Quarter 2017 Summary Oncology gross orders grew 7% Booked 23 Halcyon™ orders, 50 orders since May launch GAAP net earnings per diluted share from continuing operations of $0.89 including... Read more
October 24, 2017
Varian (NYSE: VAR) today announced five patients with brain cancer became the first patients in the US to be treated using the company's HyperArc™ High Definition Radiotherapy (HDRT), a new type... Read more
October 23, 2017
A 71-year-old eye cancer patient has become the first person in the UK, and among the first in the world, to be treated using HyperArc™ high definition radiotherapy (HDRT) technology from Varian... Read more
October 17, 2017
Varian (NYSE: VAR) today announced an 80-year-old male with head & neck cancer became the first patient in Europe to be treated on the Halcyon™ system at University Hospitals Leuven (UZ Leuven)... Read more
October 02, 2017
Varian (NYSE: VAR), global leader in radiotherapy treatments systems and software, is announcing the publication of its annual Sustainability Report, detailing the company's policies and... Read more
September 21, 2017
Crawley, U.K. — September 21st, 2017 — Cancer patients in the U.K. will gain access to the country’s first Varian Halcyon™ radiotherapy treatment devices when the first of two systems are... Read more
September 21, 2017
Varian Medical Systems (NYSE: VAR) today announced a patient at Penn Medicine, with head & neck cancer, became the first person in the world to be treated on Varian's Halcyon™ system, its new... Read more
September 20, 2017
Varian Medical Systems (NYSE: VAR) today announced it has been ranked first in eight categories, including overall manufacturer performance, overall system performance and overall service... Read more
September 19, 2017
Varian Medical Systems (NYSE: VAR) today announced it will be demonstrating its new Halcyon™ platform for simplifying and enhancing virtually every aspect of image-guided volumetric intensity... Read more
September 18, 2017
Varian Medical Systems (NYSE: VAR) today announced the newest release of its treatment planning system, Eclipse 15.5. This new release has received FDA 510(k) clearance, and incorporates several... Read more

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
[email protected]

Investor Relations Contact

Mike Bruff
VP, Investor Relations
650.424.5163
[email protected]